Literature DB >> 18200664

Special issues in pediatric inflammatory bowel disease.

Marla Dubinsky1.   

Abstract

The incidence of pediatric inflammatory bowel disease (IBD) is rising and recent advances in diagnostics and therapeutics have improved the care provided to these children. There are distinguishing features worth noting between early onset and adult onset IBD. Physical and psychosocial development remains a critical target for the comprehensive management of pediatric IBD. Children are not just little adults and consideration must be given to the stages of development and how these stages impact disease presentation and management. The final stage will be the transition from pediatric care to that of adult oriented care and special consideration must be given to make this a successful process. This review highlights special considerations in the management of the child with IBD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18200664      PMCID: PMC2679130          DOI: 10.3748/wjg.14.413

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children.

Authors:  Andrew Sawczenko; Omeia Azooz; Joanna Paraszczuk; Maja Idestrom; Nick M Croft; Martin O Savage; Anne B Ballinger; Ian R Sanderson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

2.  Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study.

Authors:  Kathleen A Calenda; Irene L Schornagel; Abdollah Sadeghi-Nejad; Richard J Grand
Journal:  Inflamm Bowel Dis       Date:  2005-05       Impact factor: 5.325

3.  Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999).

Authors:  Stéphane Auvin; Florence Molinié; Corinne Gower-Rousseau; Franck Brazier; Véronique Merle; Bruno Grandbastien; Raymond Marti; Eric Lerebours; Jean-Louis Dupas; Jean-Frédéric Colombel; Jean-Louis Salomez; Antoine Cortot; Dominique Turck
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-07       Impact factor: 2.839

4.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria.

Authors: 
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-07       Impact factor: 2.839

Review 5.  Osteoporosis and measurement of bone mass in children and adolescents.

Authors:  Laura K Bachrach
Journal:  Endocrinol Metab Clin North Am       Date:  2005-09       Impact factor: 4.741

6.  Positron emission tomography in the investigation of pediatric inflammatory bowel disease.

Authors:  Daniel A Lemberg; Robert M Issenman; Ruth Cawdron; Tim Green; John Mernagh; Stephen J Skehan; Claude Nahmias; Kevan Jacobson
Journal:  Inflamm Bowel Dis       Date:  2005-08       Impact factor: 5.325

Review 7.  Defects in mucosal immunity leading to Crohn's disease.

Authors:  Gena M Cobrin; Maria T Abreu
Journal:  Immunol Rev       Date:  2005-08       Impact factor: 12.988

8.  The bioavailability of oral methotrexate in children with inflammatory bowel disease.

Authors:  Michael C Stephens; Robert N Baldassano; Amy York; Brigitte Widemann; Aaron C Pitney; Nalini Jayaprakash; Peter C Adamson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-04       Impact factor: 2.839

9.  Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease.

Authors:  Subra Kugathasan; Anthony Loizides; Umesh Babusukumar; Erin McGuire; Tao Wang; Pleasant Hooper; Justin Nebel; Galina Kofman; Richard Noel; Ulrich Broeckel; Vasundhara Tolia
Journal:  Inflamm Bowel Dis       Date:  2005-07       Impact factor: 5.325

10.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

Authors:  Stephan R Targan; Carol J Landers; Huiying Yang; Michael J Lodes; Yingzi Cong; Konstantinos A Papadakis; Eric Vasiliauskas; Charles O Elson; Robert M Hershberg
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

View more
  27 in total

1.  Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor.

Authors:  Rachel D Thompson; Anna E Craig; Christine Mrakotsky; Athos Bousvaros; David R DeMaso; Eva Szigethy
Journal:  Compr Psychiatry       Date:  2012-06-06       Impact factor: 3.735

2.  Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease.

Authors:  Wendy N Gray; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  Inflamm Bowel Dis       Date:  2010-11-04       Impact factor: 5.325

3.  The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology.

Authors:  Kevin A Hommel; Wendy N Gray; Elizabeth Hente; Katherine Loreaux; Richard F Ittenbach; Michele Maddux; Robert Baldassano; Francisco Sylvester; Wallace Crandall; Charles Doarn; Melvin B Heyman; David Keljo; Lee A Denson
Journal:  Contemp Clin Trials       Date:  2015-05-21       Impact factor: 2.226

Review 4.  Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.

Authors:  Ioannis D Kostakis; Kyriaki G Cholidou; Aristeidis G Vaiopoulos; Ioannis S Vlachos; Despina Perrea; George Vaos
Journal:  Dig Dis Sci       Date:  2012-08-17       Impact factor: 3.199

5.  The histopathological approach to inflammatory bowel disease: a practice guide.

Authors:  Cord Langner; Fernando Magro; Ann Driessen; Arzu Ensari; Gerassimos J Mantzaris; Vincenzo Villanacci; Gabriel Becheanu; Paula Borralho Nunes; Gieri Cathomas; Walter Fries; Anne Jouret-Mourin; Claudia Mescoli; Giovanni de Petris; Carlos A Rubio; Neil A Shepherd; Michael Vieth; Rami Eliakim; Karel Geboes
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

6.  Treatment adherence in adolescents with inflammatory bowel disease: the collective impact of barriers to adherence and anxiety/depressive symptoms.

Authors:  Wendy N Gray; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  J Pediatr Psychol       Date:  2011-11-10

Review 7.  New serological markers in pediatric patients with inflammatory bowel disease.

Authors:  Márta Kovács; Katalin Eszter Müller; Mária Papp; Péter László Lakatos; Mihály Csöndes; Gábor Veres
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  What's new in inflammatory bowel disease in 2008?

Authors:  Daniel C Baumgart
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Parenting stress predicts depressive symptoms in adolescents with inflammatory bowel disease.

Authors:  Shanna M Guilfoyle; Wendy N Gray; Michele Herzer-Maddux; Kevin A Hommel
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-09       Impact factor: 2.566

10.  Predictors of depression in youth with Crohn disease.

Authors:  Jeffrey G Clark; Arvind I Srinath; Ada O Youk; Margaret A Kirshner; F Nicole McCarthy; David J Keljo; Athos Bousvaros; David R DeMaso; Eva M Szigethy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-05       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.